Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human/Mouse/Rat RIPK1/RIP1 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB3585
This item is not returnable.
View return policy
Description
RIPK1/RIP1 Monoclonal specifically detects RIPK1/RIP1 in Human, Mouse, Rat samples. It is validated for Western Blot, Simple Western, Immunocytochemistry, Knockout Validated.Specifications
| RIPK1/RIP1 | |
| Monoclonal | |
| LYOPH | |
| Western Blot 0.5 ug/mL, Simple Western 10 ug/mL, Immunocytochemistry 8-25 ug/mL, Knockout Validated | |
| Q13546 | |
| RIPK1 | |
| E. coli-derived recombinant human RIPK1/RIP1 Met1-Asn671 Accession # Q13546 | |
| 100 μg | |
| Primary | |
| Detects human, mouse and rat RIPK1/RIP1 in Western blots. | |
| Human, Mouse, Rat | |
| Purified |
| Western Blot, Immunocytochemistry, Immunoassay | |
| 334640 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| Cell death protein RIP, EC 2.7.11.1, receptor (TNFRSF)-interacting serine-threonine kinase 1, receptor interacting protein, Receptor-interacting protein 1, receptor-interacting serine/threonine-protein kinase 1, RIP, RIP1, RIP-1, Rip1 kinase, RIPFLJ39204, Serine/threonine-protein kinase RIP | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 8737 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction